Metabolomics reveals biomarkers of opioid use disorder
Open Access
- 4 February 2021
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 11 (1) , 1-10
Abstract
Opioid use disorder (OUD) is diagnosed using the qualitative criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnostic biomarkers for OUD do not currently exist. Our study focused on developing objective biological markers to differentiate chronic opiate users with OUD from chronic opiate users without OUD. Using biospecimens from the Golestan Cohort Study, we compared the metabolomics profiles of high opium users who were diagnosed as OUD positive with high opium users who were diagnosed as OUD negative. High opium use was defined as maximum weekly opium usage greater than or equal to the median usage (2.4 g per week), and OUD was defined as having 2 or more DSM-5 criteria in any 12-month period. Among the 218 high opium users in this study, 80 were diagnosed as OUD negative, while 138 were diagnosed as OUD positive. Seven hundred and twelve peaks differentiated high opium users diagnosed as OUD positive from high opium users diagnosed as OUD negative. Stepwise logistic regression modeling of subject characteristics data together with the 712 differentiating peaks revealed a signature that is 95% predictive of an OUD positive diagnosis, a significant (p < 0.0001) improvement over a 63% accurate prediction based on subject characteristic data for these samples. These results suggest that a metabolic profile can be used to predict an OUD positive diagnosis.Keywords
This publication has 45 references indexed in Scilit:
- The basics of histamine biologyAnnals of Allergy, Asthma & Immunology, 2011
- Global metabolic profiling procedures for urine using UPLC–MSNature Protocols, 2010
- The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonistNeuropharmacology, 2009
- Opioid use affects antioxidant activity and purine metabolism: preliminary resultsHuman Psychopharmacology: Clinical and Experimental, 2009
- Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern IranInternational Journal of Epidemiology, 2009
- Effects of Smoking Cessation on Eight Urinary Tobacco Carcinogen and Toxicant BiomarkersChemical Research in Toxicology, 2009
- N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded δ-Opioid Receptors at the Cell SurfaceJournal of Biological Chemistry, 2008
- NMDA receptor subunits: function and pharmacologyCurrent Opinion in Pharmacology, 2007
- Determination and quantification of urinary metabolites after dietary exposure to acrylamideXenobiotica, 2005
- Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulationJournal of Cellular Biochemistry, 1995